Karya
Judul/Title Multidisciplinary Team Meeting in the Core of Nasopharyngeal Cancer Management Improved Quality of Care and Survival of Patients. (Published)
Penulis/Author Dr. dr. Kartika Widayati, SpPD-KHOM (1) ; Dr. dr. Camelia Herdini, M.Kes., Sp.THT-KL(K), FICS. (2); dr. Auliya Suluk Brilliant Sumpono, Sp.PA(K) (3); dr. Henry Kusumo Husodoputro, Sp.Rad.(K) (4); dr. Wigati Dhamiyati, Sp.Rad(K)OnkRad (5); Dr. dr. Sagung Rai Indrasari, M.Kes., Sp.T.H.T.K.L(K), FICS. (6); SETIYANI PUJI L (7); Yulestrina Widyastuti (8); Herindita Puspitaningtyas (9); Risa Rahmasari (10); Innayah Nur Rachmawati (11); Prof. Dr. dr. Ibnu Purwanto, Sp.PD., K.HOM. (12); dr. Nurhuda Hendra Setyawan., Sp.Rad (13); dr. Ericko Ekaputra, Sp.Onk.Rad(K) (14); dr. Susanna Hilda Hutajulu, Ph.D. Sp.PD-KHOM (15); dr. Sri Retna Dwidanarti, Sp.Rad.(K) Onk.Rad (16); dr. Torana Kurniawan, Sp.Onk.Rad (17); dr. Lidya Meidania, Sp.Onk.Rad. (18); Seize E. Yanuarta (19); dr. Mardiah Suci Hardianti, Ph.D. Sp.PD-KHOM (20); dr. Johan Kurnianda, Sp.PD-KHOM (21)
Tanggal/Date 16 2023
Kata Kunci/Keyword
Abstrak/Abstract Nasopharyngeal cancer (NPC) cases are often diagnosed in advanced stages. The complexity of clinical management for advanced-stage NPC requires thorough communication and shared decisions between medical professionals and allied teams. Incorporating a multidisciplinary team meeting (MDTM) for newly diagnosed NPC patients was chosen to facilitate collaboration and communication between physicians. This retrospective study aimed to compare the quality of care, clinical responses and survival between NPC patients treated with and without MDTM. Data on clinical responses, assessment visits, date of progression and death with progression-free survival (PFS), overall survival (OS), and hazard ratio (HR) were collected and analyzed with 95% confidence interval (CI) and significance set as P < .05. There were 87 of 178 NPC patients treated with MDTM. Revisions of diagnosis and stage occurred in 5.7% and 52.9% of cases during the MDTM. More clinical responses were achieved by patients treated with MDTM (69.0%vs 32.0%, P < .00). NPC patients who received MDTM treatment recommendation had a lower risk for progression (median PFS 59.89 months vs 12.68 months; HR 0.267, 95% CI: 0.17-0.40, P < .00) and mortality (median OS was not reached vs 13.44 months; HR 0.134, 95% CI: 0.08-0.24, P < .00) compared to patients without MDTM. Incorporating the MDTM approach into NPC management improves patients’ clinical responses and survival.
Rumpun Ilmu Bidang Kedokteran Spesialis Lain Yang Tercantum
Bahasa Asli/Original Language English
Level Internasional
Status
Dokumen Karya
No Judul Tipe Dokumen Aksi
1FULL bukti korespondensi_HSI.pdf[PAK] Bukti Korespondensi Penulis
2Multidisciplinary Team Meeting in the Core of Nasopharyngeal Cancer Management Improved Quality of Care and Survival of Patients (1).pdf[PAK] Cek Similarity
3Full bukti korespondensi _HSI revisi.pdf[PAK] Bukti Korespondensi Penulis
4Full doc NPC_HSI journal_Kartika.pdf[PAK] Full Dokumen